DRCNet Response to the
Drug Enforcement Administration
DRCNet Response to the
Drug Enforcement Administration
| Drug:: | Nandrolone (Decanoate, Phenpropionate) |
| Classification:: | Anabolic Steroid |
| CSA Schedule: | Schedule III |
| Trade or Other Names: | Nortestosterone; Durabolin; Deca-Durabolin; Deca |
| Medical Uses: | Anemia; Breast cancer |
| Physical Dependence: | Unknown |
| Psychological Dependence: | Unknown |
| Tolerance: | Unknown |
| Duration (days): | 14-21 |
| Usual Method: | Injected |
| Possible Effects: | Virilization; Acne; Testicular atrophy; Gynecomastia; Aggressive behavior; Edema |
| Effects of Overdose: | Unknown |
| Withdrawal Syndrome: | Possible Depression |
Travel back to the DRCNet Response to the DEA Home Page
Travel back to the Drug Chart List
Travel back to the Use & Effects List